|
Status of policy
|
PMTCT policy adopted in 2001
|
SMC policy formulation in progress (2009)
|
|
Stage in R-2-P processes in 2009
|
Policy implementation stage
|
Analysis of policy feasibility and agenda setting
|
|
Type of research evidence generated
|
Implementation level evidence of effectiveness
|
Proof of concept for SMC – multi-country clinical trials (Rakia, Kisumu and Orange Farm)
|
|
Methods used for generating evidence
|
Large cohorts of program beneficiaries, i.e. children and mothers enrolled in PMTCT programs
|
Multi-country randomized clinical trial; country level acceptability surveys; service availability services
|
|
Objectives of the researchers’ policy engagement
|
To improve the national policy implementation approaches; Changes to cost-effective approaches
|
To establish global policy guidelines; establish national SMC programs; mobilize funds for SMC programs
|
|
Influential decision-making audiences
|
National technical level decision makers (MOH WHO, UNAIDS, UNICEF and EGPAF); Makerere College of Health Sciences
|
Mostly global multilateral agencies e.g. WHO, UNAIDS, Gates Foundation and NIH; MOH and political leaders i.e. president’s opinion about SMC
|
|
Secondary audiences
|
Implementers of PMTCT programs; Funding agencies of PMCTC programs; WHO and UNAIDS (validation of their guidelines)
|
National level leaders, technical decision makers, media practitioners; general public; HIV funding agencies; Implementers (e.g. hospital managers and surgeons)
|
|
Methods for engaging national level decision makers
|
Researchers are integrated into decision-making fora e.g. PMTCT National Advisory Committee and committees
|
Transactional or “arms-length” engagement methods by researchers e.g. occasional dissemination events, policy briefings and mass media.
|
